With RANKL/RANK being fundamental in the vicious cycle of bone metastasis in BC, a wide variety of newly considered therapeutic strategies aim to intervene, both directly or indirectly in this cross-talk. This evidence concerns the gene TNFRSF11A and breast cancer.